Latest News
All Times Eastern
- Bond yields steady before payrolls after week of big price gains
- These analysts say the office and apartment building worries after NYCB are like Groundhog Day — but do concede one issue
- Car loaded with gas in Kenya explodes and sets off inferno that injures more than 270, kills at least 33
- Barron's Energy Stocks Have Struggled. Why They Shine as Dividend Payers.
- Barron's Philip Morris Stock Stands to Get a Boost From Earnings
- Barron's Brazil Is Having a Great Time. 5 Stocks to Play.
- Barron's Boeing’s Troubles Aren’t Going Away. How to Profit From Its Problems.
- Barron's The 6% Commission for Home Sales Is Under Attack. Inside the Fight to Keep It Alive.
- Prosecutors weigh perjury charge for ex-Trump CFO Allen Weisselberg over civil fraud trial testimony
- Shares of China’s Landsea Green rise on plan to buy Texas homebuilder for $185 million
to be replaced
Bristol Myers Squibb Co.
BMYUS
$
0.19
0.39%
Premarket
$
48.86
Before Hours Volume:
769
| Close | Chg | Chg % |
|---|---|---|
| $48.67 | -0.20 | -0.41% |
Volume: 20.42M
65 Day Avg: 15.37M
48.13
Day Range
48.85
48.13
52 Week Range
75.18
Partner Center
Your Watchlists
Recently Viewed Tickers
Overview
BMY Overview
Key Data
- Open $48.85
- Day Range 48.13 - 48.85
- 52 Week Range 48.13 - 75.18
- Market Cap $99.44B
- Shares Outstanding 2.03B
- Public Float 2.03B
- Beta 0.50
- Rev. per Employee $1.310M
- P/E Ratio 12.34
- EPS $3.94
- Yield 4.93%
- Dividend $0.60
- Ex-Dividend Date Jan 4, 2024
- Short Interest 29.19M 01/12/24
- % of Float Shorted 1.44%
- Average Volume 15.37M
Performance
| 5 Day |
|
| 1 Month |
|
| 3 Month |
|
| YTD |
|
| 1 Year |
|
Analyst Ratings
Number of Ratings 27
Full Ratings
Recent News
Biotech and Pharma GSK’s RSV Vaccine Is a Blockbuster After Just 4 Months. The Stock Is Up.
Biotech and Pharma Biotech Stocks Were Tanking. The Cure? M&A.
Amazon, Apple And 3 Stocks To Watch Heading Into Friday
on Benzinga.com
Bristol-Myers Squibb's Earnings Outlook
on Benzinga.com
Biotech Bulls: 3 Stocks With Buying Potential
on StockNews.com
Market Today: Electric Vehicle Stocks Surge as Lucid Leads Rally
Market Today: Electric Vehicle Stocks Surge as Lucid Leads Rally
on GuruFocus.com
3 Healthcare Stocks at 52-Week Lows: Buy or Bye?
on InvestorPlace.com
Is Bristol Myers Squibb Stock a Buy Now?
on Motley Fool
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Competitors
| Name | Chg % | Market Cap |
|---|---|---|
| Johnson & Johnson | $382.52B | |
| Pfizer Inc. | $152.9B | |
| Abbott Laboratories | $196.44B | |
| AbbVie Inc. | $290.25B | |
| Merck & Co. Inc. | $306.06B | |
| Novartis AG | CHF184.9B | |
| AstraZeneca PLC ADR | $207.28B | |
| AstraZeneca PLC | £162.77B | |
| Sanofi S.A. | €117.31B | |
| GSK PLC | £64.15B |